NHGRI Analysis Visualizationand Informatics Lab-space



Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR Project)

CCDGphs000160.v1.p1dbGapdbGap FHIR


Multiplex Family StudyThe purpose of the NIA Genetics Initiative: Multiplex Family Study is to identify families with

multiple members diagnosed with late-onset Alzheimer's Disease. Families will be characterized clinically and blood samples will be

collected to establish cell lines. If a blood sample is not available, autopsy samples will be collected for DNA extraction and storage.

Our goal is to recruit 1,000 families over the course of the study. Clinical and demographic data from these families will be

collected at the local site and coded data, without identifiers, will be sent and included in a national database of families

with Alzheimer's Disease. This database, along with the biological samples, will be housed at the National Cell

Repository for Alzheimer's Disease (NCRAD) at Indiana University. The Center or provider and the Cell Repository must sign a

Material Transfer Agreement for shipment of biological samples and phenotypic data to NCRAD. The biological samples and data from

these families will be available to qualified researchers, who must sign a Material Transfer Agreement before receiving DNA and data.

An oversight committee known as the Cell Bank Advisory Committee (CBAC) will review and monitor the process of family identification

and enrollment, data collection, the establishment of cell lines and access to samples.

LOAD CIDR ProjectThe first 362 families of the Multiplex Family Study (including 2,105 family members) were included in a

6K SNP genome-wide scan at the NIH-supported, Center for Inherited Disease Research (CIDR). An additional 297 unrelated, healthy controls

were also genotyped at CIDR. The average age of onset of AD in the genotyped sample is 74 years and 62% of the sample is women. While

primarily Caucasian, 3% are African-American, and 3% are of Hispanic ancestry. 72% of the families had at least 2 affected siblings,

whereas 21% had 3 or more sampled affected individuals and 7% had 4 or more genotyped, affected family members.


24.49 TBSize


Consent CodesConsortia Access Only
DiseasesAlzheimer's disease
AccessConsortium Access Only
Study DesignTBD
Data TypesWhole Genome

Terra Workspaces

This study has been divided into the following workspaces by consent codes and optionally the originating laboratory.

Terra Workspace NameConsent CodeDiseaseAccessStudy DesignData TypeSamplesParticipantsSize (TB)
AnVIL_CCDG_NYGC_NP_Alz_LOAD_WGSConsortia Access OnlyAlzheimer's diseaseTBDWhole Genome1,0491,04924.49